For the Quarter Ending December 2025
Cetirizine Dihydrochloride Prices in North America
- In USA, the Cetirizine Dihydrochloride Price Index fell by 1.07% quarter-over-quarter, reflecting ample imports and inventory.
- The average Cetirizine Dihydrochloride price for the quarter was approximately USD 186633.33/MT, based on CFR Houston trade assessment.
- Downstream formulators maintained conservative purchasing, tempering Cetirizine Dihydrochloride Demand Outlook amid high distributor inventories levels.
- Competitive export offers pressured the Cetirizine Dihydrochloride Spot Price, reflecting exporter volume discipline and freight easing.
- Freight and logistics cost reductions slightly improved landed margins, moderating Cetirizine Dihydrochloride Production Cost Trend
- Inventory overhang at Gulf warehouses limited spot tightness while Cetirizine Dihydrochloride Price Forecast projects modest near-term upside.
- Major API producers remained operational, capping volatility and keeping the Cetirizine Dihydrochloride Price Index relatively stable.
- Seasonal lull after allergy peak constrained demand pull, delaying restocking and flattening immediate Cetirizine Dihydrochloride Price movement.
Why did the price of Cetirizine Dihydrochloride change in December 2025 in North America?
- High import volumes and distributor inventories created a supply overhang.
- Falling ocean freight reduced landed costs, but exporters absorbed savings.
- Post season lull kept downstream buying moderate while policy unchanged.
Cetirizine Dihydrochloride Prices in APAC
- In China, the Cetirizine Dihydrochloride Price Index rose by 0.03% quarter-over-quarter, reflecting balanced supply conditions.
- The average Cetirizine Dihydrochloride price for the quarter was approximately USD 186173.33/MT, supporting stable procurement.
- Cetirizine Dihydrochloride Spot Price remained stable as bonded-warehouse inventories matched seasonal averages, limiting abrupt volatility.
- Cetirizine Dihydrochloride Price Forecast anticipates modest gains due to end-year maintenance and cautious restocking behavior.
- Cetirizine Dihydrochloride Production Cost Trend shows slight upward pressure from precursors and higher utility costs.
- Cetirizine Dihydrochloride Demand Outlook remains seasonally supportive with hospital restocking and ecommerce promotions sustaining procurement.
- Cetirizine Dihydrochloride Price Index was constrained by comfortable bonded inventories and limited certified European allocations.
- Major suppliers ran operations with minor European maintenance reducing certified exports and tightening spot availability.
Why did the price of Cetirizine Dihydrochloride change in December 2025 in APAC?
- European API plant maintenance tightened certified export allocations, modestly reducing available CFR material into China.
- Domestic procurement remained steady for winter formulations, but cautious restocking limited strong demand-driven price increases.
- Renminbi appreciation trimmed landed costs while freight and logistics were stable, tempering larger upward price pressure.
Cetirizine Dihydrochloride Prices in Europe
- In Germany, the Cetirizine Dihydrochloride Price Index rose by 0.24% quarter-over-quarter, reflecting marginal import stability.
- The average Cetirizine Dihydrochloride price for the quarter was approximately USD 186993.33/MT, reflecting landed costs.
- Cetirizine Dihydrochloride Spot Price remained firm through December as Asian replacement costs edged slightly higher.
- Short-term Cetirizine Dihydrochloride Price Forecast indicates slight upward bias from logistics normalization and steady demand.
- Indian feedstock availability kept Cetirizine Dihydrochloride Production Cost Trend subdued despite elevated German energy tariffs.
- Continued contract manufacturing and chronic prescription volumes underpin the Cetirizine Dihydrochloride Demand Outlook through winter.
- Inventory buffers and muted restocking kept the Cetirizine Dihydrochloride Price Index largely rangebound during December.
- German domestic synthesis remained uneconomic versus Asian offers, limiting local supply and supporting import reliance.
Why did the price of Cetirizine Dihydrochloride change in December 2025 in Europe?
- Ample Asian export flows maintained supply abundance, reducing upward price pressure for German landed API.
- Elevated German energy tariffs increased domestic production costs, rendering local output uncompetitive against Asian offers.
- Logistics normalization lowered freight premia, reducing landed cost volatility and enabling importers to delay restocking.
For the Quarter Ending September 2025
North America
- In the USA, the Cetirizine Dihydrochloride Price Index fell by 0.25% quarter-over-quarter, reflecting importer frontloading.
- The average Cetirizine Dihydrochloride price for the quarter was approximately USD 186653.33/MT, CFR Houston market.
- Importers accelerated purchases pushed the Cetirizine Dihydrochloride Spot Price higher amid port congestion and logistics.
- Short-term order flows and policy uncertainty inform the Cetirizine Dihydrochloride Price Forecast indicating modest stability.
- Rising freight and handling charges influenced the Cetirizine Dihydrochloride Production Cost Trend, increasing landed costs.
- Steady end-user consumption combined with strategic restocking shapes the Cetirizine Dihydrochloride Demand Outlook near term.
- Inventory accumulation at ports and warehouses tightened availability, exerting upward pressure on the Price Index.
- Suppliers selectively raised offers while major producers remained operational, limiting downside and reducing volatility significantly.
- Why did the price of Cetirizine Dihydrochloride change in September 2025 in North America?
- Pre-emptive importer buying ahead of tariff measures concentrated demand, tightening short-term supply and elevating costs.
- Port congestion and higher freight raised landed costs, prompting suppliers to increase offers for imports.
- Stable pharmaceutical demand and strategic restocking limited inventory declines, supporting modest price resilience through September.
APAC
- In China, the Cetirizine Dihydrochloride Price Index fell by 0.45% quarter-over-quarter, reflecting stable Indian imports.
- The average Cetirizine Dihydrochloride price for the quarter was approximately USD 186116.67/MT, based on reported shipments.
- Cetirizine Dihydrochloride Spot Price movements remained muted as steady imports kept short-term transactional volumes predictable.
- Cetirizine Dihydrochloride Price Forecast projects modest oscillation while the Price Index reflects balanced supply and demand.
- Cetirizine Dihydrochloride Production Cost Trend shows limited upward pressure from freight and input chemical costs.
- Cetirizine Dihydrochloride Demand Outlook remains steady, supported by formulation schedules and seasonal allergy medication requirements.
- Rising inventories after August restocking pressured the Price Index, while export demand provided intermittent support.
- Major producers maintained operations; Cetirizine Dihydrochloride Price Index stability benefited from reliable Indian supplier deliveries.
Why did the price of Cetirizine Dihydrochloride change in September 2025 in APAC?
- Consistent Indian imports prevented shortages, limiting upward pressure despite moderate freight cost increases affecting margins.
- Cautious distributor purchasing and holiday-related inventory adjustments temporarily tightened supply chains and transactional availability conditions.
- Downstream steady demand from formulators sustained volumes, moderating price declines amid cautious market sentiment overall.
Europe
- In Germany, the Cetirizine Dihydrochloride Price Index fell by 0.26% quarter-over-quarter, reflecting port congestion impacts.
- The average Cetirizine Dihydrochloride price for the quarter was approximately USD 186543.33/MT under CFR Hamburg delivery conditions.
- Elevated Cetirizine Dihydrochloride Spot Price reflected shorter stocks and higher freight, tightening the Price Index.
- Near-term Cetirizine Dihydrochloride Price Forecast signals modest upside as importers restock ahead of autumn congestion.
- Rising freight and handling charges influenced the Cetirizine Dihydrochloride Production Cost Trend, pressuring margins for distributors.
- Stable downstream healthcare demand supports the Cetirizine Dihydrochloride Demand Outlook despite procurement and inventory adjustments.
- Inventory drawdowns and early forward buying tightened supply, lifting the Cetirizine Dihydrochloride Price Index regionally.
- Major supplier lead times extended from berth delays and river limits, increasing supply scheduling uncertainty.
Why did the price of Cetirizine Dihydrochloride change in September 2025 in Europe?
- Severe port congestion and berth delays delayed imports, reducing available spot supply and delivery certainty.
- Higher freight surcharges and routing increased landed costs, pressuring margins and elevating short-term procurement prices.
- Importers accelerated restocking amid uncertainty, tightening available inventories while downstream demand remained steady but cautious.
For the Quarter Ending June 2025
North America
- The Price Index for Cetirizine Dihydrochloride in the USA fell from USD 190,180/MT in April to USD 185,200/MT in May, before slightly recovering to USD 186,000/MT in June, reflecting a net Q2 decline of 2.2%.
- In April, a 145% tariff on Chinese imports triggered frontloaded procurement, raising landed costs and tightening supply, which modestly lifted the price index.
- Despite inflation easing in April (CPI rose only 0.2%), demand outlook for Cetirizine Dihydrochloride remained steady due to high inventory buffering by U.S. buyers.
- Product spot price dropped 2.62% in May as pharmaceutical buyers paused procurement amid regulatory changes and tariff recalibrations.
- The introduction of the “Most Favored Nation” pricing policy on May 12 led to uncertainty, delaying purchasing decisions and altering the product price forecast.
- In May, reduced Chinese shipments (-20.8% MoM) and inventory rationalization among importers pressured the production cost trend downward.
- June saw a 0.43% uptick in the price index, driven by anticipatory buying during the U.S.–China trade truce.
- Steady domestic consumption and inflationary cost adjustments in June mildly tightened market availability.
- Forward buying ahead of Q3 placed modest upward pressure on the product spot price, stabilizing the market.
- In July 2025, with inflation easing and post-May bottlenecks clearing, the price index is likely to increase slightly as importer confidence improves.
APAC
- The Price Index for Cetirizine Dihydrochloride in China fell by 5.06% in April, with spot prices dropping to USD 190,090/MT, amid weak overseas procurement and domestic oversupply conditions.
- Domestic factories faced inventory pressure due to a contraction in the manufacturing sector, compounded by the imposition of 145% U.S. tariffs that sharply curtailed exports—affecting the product production cost trend due to inefficient operations.
- In May, the Price Index further declined by 2.65%, reaching USD 185,060/MT, as Chinese suppliers struggled with rising backlogs of unsold material and continued order hesitancy, reflecting a muted product demand outlook.
- Weak new export orders and delayed shipments in May pressured suppliers to adopt aggressive pricing strategies, especially as buyers held off amid uncertainty in trade policy.
- The June Price Index inched up by 0.35% to USD 185,700/MT, attributed to short-term export recovery following a temporary 90-day suspension of U.S. tariffs announced in mid-May.
- The spot price increase in June was supported by advanced overseas orders and rising ocean freight rates, signaling better momentum in the product price forecast.
- June saw a partial rebound in export-oriented production, alleviating some overcapacity issues, although manufacturers remained cautious about future runs, reflecting volatile product production cost trend expectations.
- Product demand outlook improved slightly in June as downstream formulation segments maintained routine procurement and U.S. buyers front-loaded orders ahead of the tariff window.
- For July 2025, prices are likely to remain stable or show mild increases, as cautious overseas buyers resume activity without aggressive restocking due to unclear U.S. trade signals.
- Inventory levels have begun to ease slightly, but the Chinese market remains broadly well-supplied, limiting the scope for a sharp upward revision in the product price forecast.
Europe
- The Cetirizine Dihydrochloride Price Index in Germany declined by 6.5% in April, followed by a 2.64% drop in May, before recovering slightly by 0.40% in June, with the product spot price shifting from USD 190,120/MT in April to USD 185,850/MT in June.
- April’s decline was due to a supply glut from diverted U.S.-bound cargoes, pre-holiday stockpiling, and weak product demand outlook from pharmaceutical sectors.
- Product production cost trend remained stable, but high inventories and rerouted supplies from Asia led to excess availability in April and May.
- May’s price drop was driven by inflationary pressure, cautious buyers, and lingering post-tariff disruptions that complicated procurement cycles.
- Severe port congestion across Hamburg, Antwerp, and Bremerhaven in May delayed replenishment and deterred fresh orders.
- By June, the Price Index increased slightly due to disrupted supply chains, worsened port congestion, and early restocking to hedge against longer lead times.
- June’s product demand outlook remained cautious, with importers buying just enough to manage supply risk without overstocking.
- Rhine River's low water levels limited inland transport, amplifying delivery concerns and adding upward pressure on spot prices.
- For July 2025, prices are likely to increase modestly as consumer sentiment improves, importers regain confidence, and shipping backlogs begin to ease.
- Stabilizing inflation and forward purchases at higher values are expected to strengthen the product price forecast for Q3.
